News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 09 - 18

3.5 Trillion Yuan! China's 2030 Goal for the Pharmaceutical Industry

China's Ministry of Industry and Information Technology, together with nine other government departments, recently issued the "15th Five-Year Plan for the Development of the Pharmaceutical Industry."The plan proposes that by 2030, China's biopharmaceutical R&D and application shall rank among the world's leading positions, the effectiveness of innovation-driven development shall be fully unleashed, and systematic breakthroughs shall be achieved in key core technologies in priority fields. Core competitiveness and international influence shall rise substantially. The b...

浏览次数：0

查看详情>>

发布时间: 2026 - 09 - 17

Hong Kong's First Five-Year Plan Unveiled! The Healthy Greater Bay Area Ushers in a Golden Five Years | Efung Knowledge Planet

Full text: approx. 2,191 Chinese characters | Reading time: approx. 3 minutesOn September 16, John Lee, Chief Executive of the Hong Kong Special Administrative Region, announced the First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026–2030) (hereinafter referred to as the "Plan") at the Legislative Council meeting, and subsequently delivered his fifth Policy Address during his term.【1】This is the first five-year plan formulated since Hong Kong's return to the motherland.When explaining the relationship between the two docum...

浏览次数：0

查看详情>>

发布时间: 2026 - 09 - 15

Efung Hardcore Sharing | From Targeting Proteins to Targeting RNA: How AI is Unlocking the Druggable Space of the Transcriptome

Modern drug discovery is built on an implicit premise: drugs act on proteins. Whether small molecules or antibodies, the essence is to find a pocket or epitope on a disease-causing protein, then bind to it and inhibit it. This paradigm has supported the pharmaceutical industry for nearly a century, and it is now approaching its ceiling—only about 1.5% of the human genome encodes proteins, of which only about ten percent are disease-related, and fewer than 700 proteins have actually been targeted by approved drugs globally to date. The vast majority of remaining disease-causing proteins—transcr...

浏览次数：3

查看详情>>

发布时间: 2026 - 09 - 12

Bridging with Capital to Forge a New Global Biotech Paradigm | Dr. Jinqiao Zhu of Evident Partners Speaks at BIOHK 2026

From September 9 to 12, 2026, the 5th Hong Kong International Biotechnology Conference and Exhibition (BIOHK 2026) was held at the Hong Kong Convention and Exhibition Centre. This year’s theme is Kaleidoscope, symbolizing a panoramic view of the industry from diverse perspectives — which mirrors the current landscape of China’s innovative drug sector: policy frameworks, capital logic and technological paradigms are all undergoing a shift. What the industry needs now is no longer a simplistic narrative, but judgment capable of weathering market cycles. Dr. Jinqiao Zhu, Founder & Chairman of...

浏览次数：2

查看详情>>